You can now order CBD ONLINE!

Check availability in your area now!

DEA Cannabis Research

BREAKING : DEA Approves Cannabis Imports For Medical Studies

DEA Lets Catalent Import International Cannabis for Research

Posted by DanaSmith on Thursday Jan 12, 2017
  11041 Views  /    4 Lights

DEA Lets Catalent Import International Cannabis for Research

 

DEA cannabis

 

When it comes to the politics of cannabis, it’s like ordering from a subscription box of infused goodies: you never know exactly what you’re going to get.

 

 

Last December, no other than the US Drug Enforcement Agency allowed Catalent to receive imported pot to be used for trials and research. Catalent Pharma Solutions is based in Somerset, New Jersey, although they applied for a Kansas City, Missouri registration and the DEA gave them the green light.

 

 

FEDERAL NOTICE OF MARIJUANA

 

The Federal Notice reads:

 

“The DEA has…determined that the registration of Catalent CTS, LLC to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971.”

 

 

Catalent operates in 31 locations where they operate to store, provide specialized production, and support logistics for controlled substances to be used and distributed for the purposes of medical trials. However, this is the first time they have ever been allowed to legally support cannabis-related clinical research.

 

 

It’s likely that Catalent will be importing supplies from Europe especially because one of their clients is UK-based GW Pharmaceuticals, the same company that makes cannabis-based medications better known as Sativex and Epidiolex. Sativex is legal for use in the US as well as 14 other countries. Epidiolex on the other hand is still being studied for its efficacy in treating a particular form of epilepsy called the Lennox-Gastaut Syndrome.

 

 

To manufacture the cannabis-based medications, GW Pharma produces their own supply. The company has a government-approved facility where they grow around 200 tons of pot each year so that they can extract the cannabinoids needed for the medicines.

 

 

Stranger Things

 

 

It’s a little odd that Catalent works in locations that aren’t exactly open to cannabis use. The medical marijuana program of New Jersey can barely even be called that. Neither the UK nor Missouri has an MMJ program, but this could actually be good news - maybe it’s a sign that the DEA is finally seeing the light?

 

 

Stay tuned as we get more information on this ground breaking decision...

 

 

 

OTHER STORIES YOU MAY ENJOY..

6630507 marijuana patent

US GOVERNMENT CAUGHT IN MARIJUANA LIE, CLICK HERE.

OR..

MK Ultra marijuana

MK ULTRA AND THE MEDICAL MARIJUANA LIE, CLICK HERE.


  Keep reading... click here  

Please log-in or register to post a comment.

Leave a Comment: